© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Alaunos Therapeutics, Inc. (TCRT) stock declined over -3.39%, trading at $1.71 on NASDAQ, down from the previous close of $1.77. The stock opened at $1.76, fluctuating between $1.71 and $1.80 in the recent session.
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and development agreement with the National Cancer Institute. The company was formerly known as ZIOPHARM Oncology, Inc. and changed its name to Alaunos Therapeutics, Inc. in January 2022. Alaunos Therapeutics, Inc. is headquartered in Houston, Texas.
Employees | 1 |
Beta | -0.5 |
Sales or Revenue | $5.00K |
5Y Sales Change% | -0.98% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Alaunos Therapeutics, Inc. (NASDAQ: TCRT) stock price is $1.71 in the last trading session. During the trading session, TCRT stock reached the peak price of $1.80 while $1.71 was the lowest point it dropped to. The percentage change in TCRT stock occurred in the recent session was -3.39% while the dollar amount for the price change in TCRT stock was -$0.06.
The NASDAQ listed TCRT is part of Biotechnology industry that operates in the broader Healthcare sector. Alaunos Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Drew C. Deniger Ph.D.
Vice President of R&D
Mr. Kevin S. Boyle Sr.
Chief Executive Officer & Director
Ms. Melinda Lackey
Senior Vice President of Legal, Admin & Sec.
Mr. Michael Wong
Vice President of Fin. & Principal Accounting Officer
Mr. Abhishek Srivastava Ph.D.
Vice President of Technical Operations
TCRT's closing price is 4.91% higher than its 52-week low of $1.63 where as its distance from 52-week high of $33.00 is -94.82%.
Number of TCRT employees currently stands at 1.
Official Website of TCRT is: https://www.alaunos.com
TCRT could be contacted at phone 346 355 4099 and can also be accessed through its website. TCRT operates from 8030 El Rio Street, Houston, TX 77054, United States.
TCRT stock volume for the day was 4.97K shares. The average number of TCRT shares traded daily for last 3 months was 24.88K.
The market value of TCRT currently stands at $2.74M with its latest stock price at $1.71 and 1.6M of its shares outstanding.